Page last updated: 2024-09-05

tolvaptan and Electrolytes

tolvaptan has been researched along with Electrolytes in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Alvear-Perez, R; Bonnet, D; De Mota, N; Estéoulle, L; Flahault, A; Girault-Sotias, PE; Iturrioz, X; Keck, M; Llorens-Cortes, C; Ramanoudjame, SM	1
Peri, A	1
Amano, A; Kato, TS; Kuroda, K; Matsushita, S; Murata, M; Nakamura, H; Shimada, A; Suzuki, H; Yamamoto, T; Yokoyama, Y	1
Kobayashi, Y; Okada, M; Okita, K; Sakaida, I; Yanase, M; Yasutake, T	1
Hirano, T; Mori, T; Nakamura, S; Onogawa, T; Yamamura, Y	1

Reviews

1 review(s) available for tolvaptan and Electrolytes

Article	Year
Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment. Expert review of endocrinology & metabolism, 2019, Volume: 14, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Awareness; Diagnosis, Differential; Electrolytes; Female; Gait; Health Status Disparities; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Models, Animal; Mutation; Rats; Receptors, Vasopressin; Tolvaptan	2019

Article

Year

Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment.

Expert review of endocrinology & metabolism, 2019, Volume: 14, Issue:1

Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Awareness; Diagnosis, Differential; Electrolytes; Female; Gait; Health Status Disparities; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Models, Animal; Mutation; Rats; Receptors, Vasopressin; Tolvaptan

2019

Trials

2 trial(s) available for tolvaptan and Electrolytes

Article	Year
The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery. BMC cardiovascular disorders, 2016, 09-13, Volume: 16, Issue:1 Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Urea Nitrogen; Coronary Artery Bypass; Coronary Artery Disease; Diuresis; Dose-Response Relationship, Drug; Electrolytes; Female; Follow-Up Studies; Humans; Male; Prognosis; Prospective Studies; Renal Elimination; Tolvaptan	2016
The pharmacokinetics and pharmacodynamics of tolvaptan in patients with liver cirrhosis with insufficient response to conventional diuretics: a multicentre, double-blind, parallel-group, phase III study. The Journal of international medical research, 2012, Volume: 40, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diuretics; Double-Blind Method; Electrolytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Tolvaptan	2012

Article

Year

The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery.

BMC cardiovascular disorders, 2016, 09-13, Volume: 16, Issue:1

Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Urea Nitrogen; Coronary Artery Bypass; Coronary Artery Disease; Diuresis; Dose-Response Relationship, Drug; Electrolytes; Female; Follow-Up Studies; Humans; Male; Prognosis; Prospective Studies; Renal Elimination; Tolvaptan

2016

The pharmacokinetics and pharmacodynamics of tolvaptan in patients with liver cirrhosis with insufficient response to conventional diuretics: a multicentre, double-blind, parallel-group, phase III study.

The Journal of international medical research, 2012, Volume: 40, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diuretics; Double-Blind Method; Electrolytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Tolvaptan

2012

Other Studies

2 other study(ies) available for tolvaptan and Electrolytes

Article	Year
A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia. Nature communications, 2021, 01-12, Volume: 12, Issue:1 Topics: Amino Acid Sequence; Animals; Apelin; Apelin Receptors; Arginine Vasopressin; Blood Glucose; Blood Pressure; Cell Line; Colforsin; Cyclic AMP; Deamino Arginine Vasopressin; Disease Models, Animal; Diuresis; Electrolytes; Half-Life; Hyponatremia; Kidney Tubules, Collecting; Male; Mice; Models, Biological; Myocardial Contraction; Peptides; Phosphorylation; Rats, Sprague-Dawley; Tolvaptan	2021
Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats. The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:1 Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrolytes; Furosemide; Hormones; Male; Osmolar Concentration; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Sodium; Tolvaptan; Water	2000

Article

Year

A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia.

Nature communications, 2021, 01-12, Volume: 12, Issue:1

Topics: Amino Acid Sequence; Animals; Apelin; Apelin Receptors; Arginine Vasopressin; Blood Glucose; Blood Pressure; Cell Line; Colforsin; Cyclic AMP; Deamino Arginine Vasopressin; Disease Models, Animal; Diuresis; Electrolytes; Half-Life; Hyponatremia; Kidney Tubules, Collecting; Male; Mice; Models, Biological; Myocardial Contraction; Peptides; Phosphorylation; Rats, Sprague-Dawley; Tolvaptan

2021

Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.

The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:1

Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrolytes; Furosemide; Hormones; Male; Osmolar Concentration; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Sodium; Tolvaptan; Water

2000